Edgewise Therapeutics, Inc. (EWTX)

NASDAQ

$36.71

$-1.69

(-4.40%)

Regular Market

Edgewise Therapeutics, Inc. (EWTX) Live Price Chart

Last updated: ⁦2026-10-13 18:13:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Edgewise Therapeutics, Inc. (EWTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $36.71, with a market capitalisation of $4.24B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $14.25 to $48.51. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$4.24B
Open	$38.17
Day's High	$48.51
Day's Low	$5.12
Previous Close	$38.45
Volume	291.32K
Average Volume	1.35M
P/E Ratio	--
52-Week High	$48.51
52-Week Low	$14.25
Dividend Yield	--
Earnings Date	--

Edgewise Therapeutics, Inc. (EWTX) Stock Price Today

Edgewise Therapeutics, Inc. (EWTX) is currently trading at $36.71 as of 2026-10-13 18:11:00, down 4.52% ($1.74) from the previous close of $38.45

During today's regular trading session, EWTX has traded between $5.12 and $48.51, with a trading volume of 291.32K shares. The current price is near the upper end of today's range.

Edgewise Therapeutics, Inc. (EWTX) 7-Day Stock Price Change

Over the past seven days, Edgewise Therapeutics, Inc. (EWTX) moved from $41.40 to $36.71, representing a decline of 11.33% ($4.69).

The stock traded between $36.69 and $41.94 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.45 million shares, down versus the previous seven-day period, indicating lower trading activity.

EWTX 52-Week Price Position

Position in Range: 65.6%

52W Low$14.25

52W High$48.51

EWTX is currently trading at $36.71, placing it 65.6% of the way from its 52-week low of $14.25 to its 52-week high of $48.51. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Edgewise Therapeutics, Inc. (EWTX)?

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Edgewise Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	127
Exchange	NASDAQ
Company Website	https://www.edgewisetx.com

How to Buy Edgewise Therapeutics, Inc. (EWTX) Stock on MEXC

Eligible investors can buy real shares of Edgewise Therapeutics, Inc. (EWTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for EWTX and Place Your Order

Open the RealStocks trading page and search for EWTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Edgewise Therapeutics, Inc. (EWTX) stock price today?

Edgewise Therapeutics, Inc. (EWTX) is currently trading at $ 36.71, down 4.52% ($1.74) from the previous close of $ 38.45. Intraday prices update in real time during regular trading hours.

2.Is EWTX stock going up or down today?

As of 2026-10-13 18:11:00, EWTX is trading at $ 36.71, down 4.52% ($1.74) from its previous close of $ 38.45. The stock has traded between $ 5.12 and $ 48.51 during today’s regular session. Past price movements do not guarantee future results.

3.What is EWTX pre-market price?

As of 2026-10-13 18:11:00, EWTX is trading at $ 38.28 in pre-market trading, down 0.45% ($0.17) from the previous close of $ 38.45. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is EWTX after-hours price?

As of 2026-10-13 18:11:00, EWTX is trading at $ 37.86 in after-hours trading, down 1.53% ($0.59) from the regular-session close of $ 38.45. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is EWTX stock trading now?

EWTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does EWTX sit relative to its 52-week high and low?

Over the past 52 weeks, EWTX has traded between a low of $ 14.25 and a high of $ 48.51. At $ 36.71, the stock is positioned 65.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Edgewise Therapeutics, Inc. in?

Edgewise Therapeutics, Inc. (EWTX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Edgewise Therapeutics, Inc.'s market capitalisation and where is it listed?

Edgewise Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 4.24B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is EWTX valued in terms of P/E ratio and EPS?

EWTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.82. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Edgewise Therapeutics, Inc. pay a dividend?

Edgewise Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.